Arabic version: الحكومة البريطانية توسع فحص سرطان البروستاتا للرجال السود

Tens of thousands more black men aged 45-74 are to be invited for prostate cancer checks as part of an ongoing trial in the UK to find better ways of testing for the disease. This initiative aims to improve testing methods for the disease and has been welcomed by charities and campaigners as a “truly historic moment.” According to BBC News, the government plans to invest £18 million into the Transform trial to facilitate this expansion.

The UK National Screening Committee recently advised that most men should not undergo regular prostate cancer testing, citing concerns that the potential harms of the PSA blood test outweigh its benefits for the majority. The recommendation primarily applies to men without symptoms, as the committee emphasizes that only a few thousand men with a dangerous genetic variant and a family history of cancer should be screened regularly.

Prostate cancer remains the most common cancer in men in the UK, with 64,000 men diagnosed and 12,000 dying each year. The risk is notably higher for black men, with one in four expected to develop the disease in their lifetime, compared to one in eight for the general male population.

The Transform trial will explore the effectiveness of additional tests, including genetic assessments and expedited MRI scans, in enhancing screening accuracy. All black men in the specified age group who have not recently been tested will have the opportunity to participate in the trial. Health Secretary James Murray stated that this initiative represents a significant advancement in addressing prostate cancer, particularly for those at higher risk.